Irinotecan
About
Therapy type: Chemotherapy
Therapy strategy: Topoisomerase I inhibition
Mappings
NCI Thesaurus: Irinotecan (coding:ncit:C62040)
RxNorm: irinotecan (coding:rxcui:51499, coding:omop:4156721)
SNOMED: Irinotecan (coding:sctid:372538008, coding:omop:1367268)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) HC (1) | EGFR positive, Wild type KRAS | Colorectal Adenocarcinoma | Cetuximab, Fluorouracil, Irinotecan | |
| FDA (1) HC (1) | EGFR positive, Wild type KRAS | Colorectal Adenocarcinoma | Cetuximab, Irinotecan | |
| FDA (1) | BRAF p.V600E | Colorectal Adenocarcinoma | Cetuximab, Encorafenib, Fluorouracil, Irinotecan |